4,4'-[2,2,2-Trifluoro-1-(trifluoromethyl)ethylidene]bisphenol; 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]di-phenol; 4,4'-[Trifluoro-1-(trifluoromethyl)ethylidene]diphenol; 1,1,1,3,3,3-Hexafluoro-2,2-bis(4-hydroxyphenyl)propane; 2,2-(4-Hydroxyphenyl)hexafluoropropane; 2,2-Bis(4-hydroxyphenyl)-1,1,1,3,3,3-hexafluoropropane; 2,2-Bis(4-hydroxyphenyl)hexafluoropropane; 2,2-Bis(4-hydroxyphenyl)perfluoropropane; 2,2-Bis(4'-hydroxyphenyl)hexafluoropropane; 2,2-Bis(p-hydroxyphenyl)hexafluoropropane; 4,4'-(Hexafluoroisopropylidene)bisphenol; 4,4'-(Hexafluoroisopropylidene)diphenol; BIS-AF; Biphenol AF; Bisphenol AE; Bisphenol AF; Cheminox BAF; Curative 30; GP 21; Hexafluorobisphenol A; Hexafluorodiphenylolpropane; Hexafluoroisopropylidenebis(4-hydroxybenzene); NSC 152522

2,2-Bis-(4-hydroxyphenyl)hexafluoropropane acts as an endocrine-disrupting chemical (EDC), activating estrogen through the estrogen receptor ERα. It is a full agonist for the estrogen receptor.